These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16497984)

  • 1. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease.
    Silvestrini M; Pasqualetti P; Baruffaldi R; Bartolini M; Handouk Y; Matteis M; Moffa F; Provinciali L; Vernieri F
    Stroke; 2006 Apr; 37(4):1010-5. PubMed ID: 16497984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive correlates of cerebral vasoreactivity on transcranial Doppler in older adults.
    Shim Y; Yoon B; Shim DS; Kim W; An JY; Yang DW
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1262-9. PubMed ID: 25906930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia.
    Stefani A; Sancesario G; Pierantozzi M; Leone G; Galati S; Hainsworth AH; Diomedi M
    J Neurol Sci; 2009 Aug; 283(1-2):109-15. PubMed ID: 19278690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between cerebral arterial pulsatility and cognitive dysfunction in Alzheimer's disease patients.
    Lim JS; Lee JY; Kwon HM; Lee YS
    J Neurol Sci; 2017 Feb; 373():285-288. PubMed ID: 28131207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of carotid atherosclerosis in Alzheimer's disease progression.
    Silvestrini M; Viticchi G; Falsetti L; Balucani C; Vernieri F; Cerqua R; Luzzi S; Bartolini M; Provinciali L
    J Alzheimers Dis; 2011; 25(4):719-26. PubMed ID: 21508532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular Hemodynamics on Transcranial Doppler Ultrasonography and Cognitive Decline in Mild Cognitive Impairment.
    Lim EY; Yang DW; Cho AH; Shim YS
    J Alzheimers Dis; 2018; 65(2):651-657. PubMed ID: 30103317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.
    Urbanova BS; Schwabova JP; Magerova H; Jansky P; Markova H; Vyhnalek M; Laczo J; Hort J; Tomek A
    J Alzheimers Dis; 2018; 63(2):465-477. PubMed ID: 29614647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer's disease.
    Caamaño J; Gómez MJ; Franco A; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):211-8. PubMed ID: 7913981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between blood flow kinetics and severity of Alzheimer's disease: assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAS(cog)).
    Nebu A; Ikeda M; Fukuhara R; Shigenobu K; Maki N; Hokoishi K; Komori K; Yasuoka T; Tanabe H
    Dement Geriatr Cogn Disord; 2001; 12(5):318-25. PubMed ID: 11455133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deterioration in bilateral asymptomatic severe carotid stenosis.
    Buratti L; Balucani C; Viticchi G; Falsetti L; Altamura C; Avitabile E; Provinciali L; Vernieri F; Silvestrini M
    Stroke; 2014 Jul; 45(7):2072-7. PubMed ID: 24903984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease.
    Viticchi G; Falsetti L; Buratti L; Luzzi S; Bartolini M; Acciarri MC; Provinciali L; Silvestrini M
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1164-70. PubMed ID: 25754252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
    Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
    Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration.
    Balestrini S; Perozzi C; Altamura C; Vernieri F; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    Neurology; 2013 Jun; 80(23):2145-50. PubMed ID: 23624562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular Dysfunction in Alzheimer Disease: Assessment of Cerebral Vasoreactivity by Ultrasound Techniques and Evaluation of Circulating Progenitor Cells and Inflammatory Markers.
    Cipollini V; Sette G; Bossù P; Ciaramella A; Salani F; De Carolis A; Troili F; Orzi F; Giubilei F
    Alzheimer Dis Assoc Disord; 2019; 33(3):212-219. PubMed ID: 31335454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.